Top Markets
#1 MowCat MowCat +48.51%
#2 Bitway Bitway +28.60%
#3 Velvet Velvet +25.02%
#4 Fake World Assets Fake World Assets +24.70%
#5 aPriori aPriori +24.35%
#6 OVERTAKE OVERTAKE +20.74%
#7 Zerebro Zerebro +17.04%
#8 Verus Coin Verus Coin +16.08%
#9 Derive Derive +14.93%
#10 Biconomy Biconomy +13.92%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
주식 순위 #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
주가
$0.04895618
마지막 동기화: 2025-03-18
시가총액
$5.55M
변동 (1일)
-0.04%
변동 (1년)
0.00%
국가
CA
거래 WPD Pharmaceuticals Inc. (WBIO)

카테고리

Healthcare
WPD Pharmaceuticals Inc. (WBIO)의 매출
Aug 2026 기준 매출 TTM: 0
WPD Pharmaceuticals Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
WPD Pharmaceuticals Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE